Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +441518081136

Opinion Article - Journal of Medical Oncology and Therapeutics (2023) Volume 8, Issue 5

Understanding Hormone Therapy in Cancer Treatment

Lindsay Morgan *

Department of Plastic and Reconstructive Surgery, Karls University Tuebingen, Germany

*Corresponding Author:
Lindsay Morgan
Department of Plastic and Reconstructive Surgery
Karls University Tuebingen
Germany
E-mail: lindsay.organ@vinzenz.de

Received: 22-Aug-2023, Manuscript No. JMOT-23-112830; Editor assigned: 23- Aug -2023, PreQC No. JMOT-23-112830 (PQ); Reviewed: 06-Sep-2023, QC No. JMOT-23-112830; Revised: 14- Sep -2023, Manuscript No. JMOT-23-112830 (R); Published: 22- Sep -2023, DOI: 10.35841 /jmot-8.5.164

Citation: Morgan L. Understanding hormone therapy in cancer treatment. J Med Oncl Ther. 2023;8(5):164

Visit for more related articles at Journal of Medical Oncology and Therapeutics

Abstract

     

Introduction

Hormone therapy, also known as endocrine therapy or hormonal therapy, is a vital component of cancer treatment for several types of cancer, most notably breast and prostate cancer. This therapeutic approach is based on the manipulation of hormones in the body to slow down or stop the growth of hormone-sensitive tumors. Hormone therapy has proven to be effective in treating these specific types of cancer and has played a significant role in improving the prognosis and quality of life for many patients. In this article, we will delve into the concept of hormone therapy, its mechanisms of action, its applications, and its potential side effects. Before delving into the intricacies of hormone therapy, it's crucial to grasp the role of hormones in cancer. Hormones are chemical messengers produced by various glands in the endocrine system. They play pivotal roles in regulating various bodily functions, including growth, metabolism, and the immune system. Some hormones can also influence the growth and behavior of certain types of cancer cells. Certain cancers are hormone-sensitive, meaning they are influenced or driven by the presence of specific hormones. The two most common hormone-sensitive cancers are breast cancer and prostate cancer [1].

Estrogen and progesterone are the primary hormones that influence the growth of breast cancer cells in many cases. These hormones can attach to receptors on the surface of breast cancer cells, fueling their growth. Breast cancers that have these hormone receptors are called hormone receptor-positive (HR+), and hormone therapy is often a key part of their treatment. The growth of prostate cancer cells is largely dependent on the male hormone testosterone. Reducing the levels of testosterone can slow down or stop the growth of these cancer cells. Prostate cancer treated with hormone therapy is referred to as hormone-sensitive prostate cancer. Hormone therapy works by altering hormone levels in the body or by blocking hormone receptors on cancer cells. The specific approach depends on the type of cancer and the goals of treatment. Here are the primary mechanisms of hormone therapy.Hormone Suppression: In some cases, hormone therapy aims to reduce the production of hormones that fuel cancer growth. For example, in breast cancer, drugs like tamoxifen or aromatase inhibitors can be used to inhibit the production of estrogen or block its action [2].

Hormone Receptor Blockade: Another approach is to block hormone receptors on cancer cells so that hormones cannot attach and stimulate cell growth. This is common in prostate cancer treatment, where drugs like LHRH agonists or anti-androgens are used to block testosterone's effects. Hormone therapy is a cornerstone of treatment for hormone receptor-positive breast cancer. It is often used in conjunction with surgery, radiation, and chemotherapy. The choice of specific hormone therapy drugs depends on various factors, including the patient's age and menopausal status [3].

Other Cancers: Hormone therapy may also be considered for other hormone-sensitive cancers, such as ovarian and endometrial cancers. In these cases, the specific approach may vary, but the underlying goal is to inhibit hormone-driven tumour growth. In breast cancer, hormone therapy is frequently used as adjuvant therapy after surgery or radiation to reduce the risk of cancer recurrence. In advanced or metastatic cancer cases, hormone therapy can be used as palliative care to alleviate symptoms and improve the patient's quality of life [4].

Many women receiving hormone therapy for breast cancer experience menopausal symptoms like hot flashes, mood swings, and vaginal dryness. Some hormone therapy drugs can affect bone density, potentially increasing the risk of osteoporosis. Monitoring and management of bone health are important in long-term hormone therapy. In some cases, hormone therapy may slightly increase the risk of cardiovascular problems. Patients should discuss their cardiovascular health with their healthcare team. Hormone therapy can affect fertility, and patients of childbearing age should discuss fertility preservation options with their healthcare providers before starting treatment. The duration of hormone therapy varies depending on the type and stage of cancer. Some patients may need long-term treatment [5].

Conclusion

Hormone therapy is a valuable tool in the treatment of hormone-sensitive cancers like breast and prostate cancer. By either reducing hormone production or blocking hormone receptors on cancer cells, this approach effectively slows down or halts tumor growth, improving patients' quality of life and survival rates. However, it's essential for patients and their healthcare teams to carefully weigh the benefits and potential side effects of hormone therapy and tailor treatment plans to individual needs. Ongoing research continues to refine hormone therapy techniques and expand its applications, offering hope for better outcomes for cancer patients in the future.

References

  1. Kosorok MR, Laber EB. Precision medicine. Annu Rev Stat Appl. 2019;6:263-86.

    2. Google Scholar, Cross Ref

  2. Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507-22.

    3. Indexed at , Google Scholar, Cross Ref

  3. König IR, Fuchs O, Hansen G,et al. What is precision medicine?. Eur Respir J. 2017 1;50(4).

    4. Indexed at , Google Scholar, Cross Ref

  4. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-5.

    5. Indexed at , Google Scholar, Cross Ref

  5. Bahcall O. Precision medicine. Nature. 2015 526(7573):335.

    6.  Google Scholar, Cross Ref

Get the App